
|Articles|November 2, 2017
New Site Metrix Helps Pharma Inform Clinical Trial Plans
Advertisement
KMR Group announces its newest release of Site Metrix Application which provides clinical site performance benchmarks to the biopharma industry. The application will be used to help biopharma in the performance evaluation of their sites and set realistic site level enrollment plans. Accessing this data will no longer pose a challenge as well.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves Oral Wegovy Following Positive Phase III OASIS 4 Trial Results
2
Controlled Clinical Trials in Sub-Saharan Africa: A Winning Value Proposition
3
FDA Approves Subcutaneous Lunsumio VELO Based on GO29781 Trial Results in Relapsed or Refractory Follicular Lymphoma
4
ACT Brief: Building a Digital Thread in Life Sciences, CRO Sourcing Decisions and Site Burden, and Lilly’s Oral GLP-1 Phase III Results
5




